1315 Capital

Summary

1315 Capital appeared to be the VC, which was created in 2014. The main office of represented VC is situated in the Philadelphia. The fund was located in North America if to be more exact in United States.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Colorescience, Onkos Surgical, Encore Dermatology The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are Cosmetics, Medical. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.

The typical startup value when the investment from 1315 Capital is 50-100 millions dollars. The high activity for fund was in 2017. Despite it in 2019 the fund had an activity. Opposing the other organizations, this 1315 Capital works on 9 percentage points less the average amount of lead investments. Considering the real fund results, this VC is 20 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2012. The fund is constantly included in less than 2 deals per year.

The fund was created by Adele C. Oliva, Michael Koby. Besides them, we counted 4 critical employees of this fund in our database.

The typical case for the fund is to invest in rounds with 2-3 participants. Despite the 1315 Capital, startups are often financed by Split Rock Partners, Montreux Equity Partners, Longwood Founders Fund. The meaningful sponsors for the fund in investment in the same round are Montreux Equity Partners, Longitude Capital, Horizon Technology Finance. In the next rounds fund is usually obtained by Canaan Partners, 3D Systems.